Differences in self-peptide binding between T1D-related susceptible and protective DR4 subtypes.
HLA-DR0401, 0403 and 0405 are associated with variable T1D susceptibilities when linked with a common HLA-DQ8 (DQA1∗0301/DQB1∗0302). It is unknown how the modest differences within the peptide binding regions of DR4 subtypes lead to distinct autoimmune risks. Since all Class II HLA molecules share the same intracellular compartments during biosynthesis, it is possible that DQ and DR compete with one another to bind and present antigenic peptides. As such, it is reasonable to hypothesize that a strong DR4 self-peptide binder down-modulates DQ8 epitope presentation more than a weak one. In this study, we first examined the binding of the peptides derived from two putative beta-cell autoantigens - GAD65 and insulin. Protective DR0403 bound similar number of self-peptides as susceptible DR0401 while highly susceptible DR0405 bound substantially less self-peptides than rest two molecules. Kinetic assays were used to further compare the stability of peptide:DR complexes formed between DR0401, 0403 and selected GAD65 peptides, which also bound DQ8. Two peptides with naturally processed DQ8 epitopes bound protective DR0403 with longer half-life and lower dissociation rate than susceptible DR0401, confirming DR0403 as a better peptide competitor than DR0401. The distinguishing peptide binding features of DR0401, DR0403, and DR0405 highlighted in this study help to explain the hierarchy of genetic associations between T1D and these DR4 subtypes. The enhanced peptide competition of DR0403 leads to a down-modulation of DQ8 epitope presentation, as compared to weak competitors such as DR0401 and DR0405, and therefore contributes to disease protection.
Benaroya Research Institute at Virginia Mason, Seattle, WA 98101, USA.
Xinhui
X
Ge
Eddie A
EA
James
Helena
H
Reijonen
William W
WW
Kwok
D000595:Amino Acid Sequence; D001324:Autoantigens / Q000276:immunology / Q000378:metabolism; D001667:Binding, Competitive / Q000276:immunology; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology / Q000378:metabolism; D003922:Diabetes Mellitus, Type 1 / Q000235:genetics / Q000276:immunology* / Q000378:metabolism; D000939:Epitopes / Q000235:genetics / Q000276:immunology / Q000378:metabolism; D020022:Genetic Predisposition to Disease; D005968:Glutamate Decarboxylase / Q000276:immunology; D006683:HLA-DQ Antigens / Q000235:genetics / Q000276:immunology* / Q000378:metabolism; D059848:HLA-DQ alpha-Chains; D059866:HLA-DQ beta-Chains; D006684:HLA-DR Antigens / Q000235:genetics / Q000276:immunology* / Q000378:metabolism; D006801:Humans; D007328:Insulin / Q000276:immunology; D007700:Kinetics; D008969:Molecular Sequence Data; D010455:Peptides / Q000235:genetics / Q000276:immunology* / Q000378:metabolism; D011485:Protein Binding
D001324:Autoantigens; D000939:Epitopes; D006683:HLA-DQ Antigens; D059848:HLA-DQ alpha-Chains; D059866:HLA-DQ beta-Chains; C109756:HLA-DQ8 antigen; C069050:HLA-DQA1 antigen; C069051:HLA-DQB1 antigen; D006684:HLA-DR Antigens; D007328:Insulin; D010455:Peptides; D005968:Glutamate Decarboxylase; C401141:glutamate decarboxylase 2
Ann N Y Acad Sci. 2004 Dec;1037:96-103
15699499
Pharm Res. 2006 Feb;23(2):227-42
16323065
Diabetes. 1990 Nov;39(11):1315-9
2227105
J Clin Invest. 1999 Dec;104(12):R63-7
10606632
Diabetes. 1982 Feb;31(2):136-44
6759229
Hum Immunol. 1995 Aug;43(4):301-8
7499178
Nature. 1987 Oct 15-21;329(6140):599-604
3309680
Endocr Rev. 1994 Aug;15(4):516-42
7988484
Diabetes. 1997 Jan;46(1):143-9
8971095
J Clin Invest. 1996 Dec 1;98(11):2597-603
8958223
Diabetes. 2002 Feb;51(2):545-51
11812768
J Clin Invest. 2001 Apr;107(7):871-80
11285306
Diabetes. 2008 Apr;57(4):1084-92
18252895
J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Feb 1;14(2):91-101
9052717
Diabetes. 2005 Oct;54(10):2995-3001
16186404
J Immunol. 1999 Dec 1;163(11):6275-82
10570321
N Engl J Med. 1984 Jul 19;311(3):149-52
6738600
J Immunol. 1998 Dec 1;161(11):6439-45
9834137
Diabetes. 1990 Oct;39(10):1153-7
2210067
Nat Immunol. 2001 Jun;2(6):501-7
11376336
Hum Immunol. 1988 Dec;23(4):289-99
3266208
Tissue Antigens. 2003 Nov;62(5):359-77
14617043
Annu Rev Immunol. 1990;8:647-79
2188676
Diabetes. 2006 Dec;55(12):3455-62
17130492
J Clin Invest. 1989 Mar;83(3):830-5
2784133
Biochemistry. 2000 Apr 4;39(13):3751-62
10736175
Proc Natl Acad Sci U S A. 1988 Nov;85(21):8111-5
3186714
J Immunol. 1994 May 15;152(10):4946-57
8176213
Diabetes. 2004 Oct;53(10):2684-90
15448101
Diabetes. 2008 Jul;57(7):1852-60
18398138
J Immunol Methods. 2003 Oct 1;281(1-2):129-42
14580887
J Exp Med. 1999 Jun 7;189(11):1723-34
10359576